User: Guest  Login
Title:

Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation.

Document type:
Clinical Trial; Controlled Clinical Trial; Journal Article; Article
Author(s):
Lersch, C; Schmelz, R; Erdmann, J; Hollweck, R; Schulte-Frohlinde, E; Eckel, F; Nader, M; Schusdziarra, V
Abstract:
BACKGROUND/AIMS: New perspectives in the treatment of advanced hepatocellular carcinomas have recently been inaugurated with the application of hydroxymethylglutaryl coenzyme A reductase inhibitors i.e. pravastatin, the somatostatin analogue octreotide, or the cytidine analogue gemcitabine. The present study aimed to evaluate these substances in patients with progressive tumor growth. METHODOLOGY: A total of 58 patients either received 3 x 200 microg/day octreotide for 2 months followed by 20mg...     »
Journal title abbreviation:
Hepatogastroenterology
Year:
2004
Journal volume:
51
Journal issue:
58
Pages contribution:
1099-103
Language:
eng
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/15239254
Print-ISSN:
0172-6390
TUM Institution:
Else Kröner-Fresenius-Zentrum für Ernährungsmedizin - Klinik für Ernährungsmedizin; II. Medizinische Klinik und Poliklinik (Gastroenterologie); Institut für Medizinische Statistik und Epidemiologie
 BibTeX